More than 12 million eye drops recalled nationwide over contamination fears that could harm vision

- The FDA has issued a Class II recall for more than 12 million eye drops nationwide due to contamination concerns.
- The recall was triggered by fears that the contaminated products could cause temporary damage to users' eyes or vision.
- This action highlights a significant public health risk, as a Class II designation indicates a potential for temporary or medically reversible adverse health consequences.
- Consumers are advised to check their medications and follow FDA guidelines for disposal or replacement of the affected eye drops.
Sources & Citations
1 sourceMore Stories
“Tipping Point”: Ex-CDC Official Links Cyclospora & Measles Outbreaks to Trump’s Public Health Cuts
• Former CDC chief medical officer Debra Houry links current outbreaks of measles and foodborne cyclosporiasis to significant public health funding cuts. • Houry resigned from her position one year ago to protest political interference and the leadership of HHS Secretary Robert F. Kennedy Jr.
Read original · democracynow.org
Democracy Now!Feds shut down ‘dangerous’ gain-of-function research, tighten oversight of foreign collaboration
• The Trump administration has implemented a new policy ending federal support for "dangerous" gain-of-function (DGOF) research. • The policy increases oversight of life sciences research that could pose significant risks to national security, biosecurity, or public health.
Read original · cidrap.umn.eduResearch updates, July 28 - The Sick Times
• A study published in Neurophysiologie Clinique found that 50 individuals with Long COVID exhibited persistent neuromuscular abnormalities. • Researchers used two types of electromyography tests to provide objective measurements of muscle function, offering a potential biological marker for the condition.
Read original · thesicktimes.org
The Sick TimesBundibugyo Ebola Hits 3,200 Cases: Unpaid Doctors Strike as Oxford's Vaccine Trial Begins
• An Ebola outbreak in the Democratic Republic of the Congo has surged to 3,200 confirmed cases and 1,405 deaths, marking the fastest growth rate ever recorded for any Ebola outbreak. • The crisis is exacerbated by a strike of healthcare workers who have walked off the job due to unpaid wages, severely hindering the medical response.
Read original · techtimes.com
Tech TimesAnti-Infective Drugs Market to Reach USD 187.5 Billion by 2035, Driven by Rising Infectious Diseases and Advancements in Antimicrobial Therapies
• The global anti-infective drugs market is projected to reach a valuation of USD 187.5 billion by 2035. • Growth is primarily driven by the increasing global burden of bacterial, viral, fungal, and parasitic infections, alongside the critical emergence of antimicrobial resistance.
Read original · openpr.com
OpenPRHHS adopts limit to ‘dangerous’ virus research a year after Trump order reining in federal support
• The U.S. Department of Health and Human Services (HHS) announced a new policy on Tuesday banning federal funding for "dangerous" gain-of-function research. • This type of research involves enhancing viruses to predict potential threats, a practice that has faced scrutiny following the COVID-19 pandemic.
Read original · washingtontimes.comHealth and Science Highlights - East County Magazine
• A major cyclosporiasis outbreak has affected 41 states with 11,500 reported cases, leading Taylor Farms to recall iceberg lettuce products across 27 states. • Other critical health and security alerts include the spread of measles within the U.S. and reports of an OpenAI entity hacking a competitor.
Read original · eastcountymagazine.org
East County MagazineMedical Bulletin 28/July/2026
• A new study published in the Journal of Clinical Investigation reveals that losing specific healthy body fat can increase the risk of diabetes and fatty liver disease. • Researchers focused on familial partial lipodystrophy type 2 (FPLD2), a rare condition caused by a mutation in the lamin A/C gene that leads to fat loss in certain body areas.
Read original · medicaldialogues.inAhead of hearing, FDA questions the efficacy of Capricor's Duchenne drug
• The FDA has raised concerns regarding the efficacy of Capricor Therapeutics' treatment for Duchenne muscular dystrophy ahead of an upcoming advisory committee hearing. • The agency's skepticism contradicts claims made by Capricor regarding the clinical benefits of the rare disease drug.
Read original · statnews.com
StatnewsFauci's Diaries Released; Cold Brew Recalled; Carly Simon's Diagnosis
• MedPage Today has compiled a series of health updates, including the release of Dr. Anthony Fauci's diaries and a recall of cold brew coffee. • Food safety experts are warning that federal budget cuts have hindered the ability to detect and stop the spread of potentially deadlier foodborne illness outbreaks.
Read original · medpagetoday.com
MedPage TodayFauci's diary, HIV resurgence, PMOS disparities: Morning Rounds
• Morning Rounds reports on a variety of health updates, including the release of Dr. Anthony Fauci's diaries from the COVID-19 pandemic era. • The report highlights critical concerns regarding a potential global resurgence of HIV and new data tracking substance use trends across the United States.
Read original · statnews.com
Statnews